KRAS and cancer: The advancement of the understanding of KRAS-driven carcinogenesis and its underlying mechanisms has shown that KRAS mutations are not only capable of leading to sustained proliferation and reduced apoptosis in cancer cells but can take direct influence on the TME through autocrine and paracrine effects.